🤖 This page was written by AI and reviewed by a human. 2026-07-15. Version 0.19
Francoise Bettencourt Meyers
Status
Born in 1953 (age –). Living in Paris, France.
Criminal status: No personal convictions. L'Oréal's Garnier unit was definitively convicted of racist recruitment practices in 2007, the company paid a EUR 189.5M price-fixing fine upheld in 2023, and L'Oréal faces civil mass-tort litigation in the US (hair relaxer MDL, thousands of cases).
Summary
Françoise Bettencourt Meyers is the granddaughter of L'Oréal founder Eugène Schueller and the daughter of Liliane Bettencourt. She inherited a controlling stake in L'Oréal and served on its board from 1997 to 2025, including five years as vice chair. She co-founded the Bettencourt Schueller Foundation with her parents in 1987 and has served as its president since her mother's death in 2017.
Her philanthropic work through the BSF distributes approximately EUR 54.7M annually across life sciences, arts, and social inclusion, making it one of France's largest private foundations. She is also a published author and biblical scholar who has written a multi-volume commentary on the Bible.
Business Relationships
The BSF partners with INSERM and CNRS through the ATIP-Avenir program to fund young researchers in French public laboratories. L'Oréal co-runs the For Women in Science fellowship with UNESCO, awarding annual grants to women postdoctoral scientists; the 2025 cohort of five awardees was announced in November 2025.
Ownership
Françoise and her family hold approximately 33% of L'Oréal through Téthys, the family investment company. This stake makes the Bettencourt Meyers family L'Oréal's single largest shareholder and gives them effective control over board composition. She served as board vice chair from 2020 until her retirement in April 2025, when the seat passed to Alexandre Benais (deputy CEO of Téthys) and the vice-chair role to Jean-Victor Meyers.
Family & Heirs
Françoise married Jean-Pierre Meyers in 1984. Their sons Jean-Victor Meyers and Nicolas Meyers are both on the L'Oréal board. Her mother Liliane Bettencourt died in September 2017, leaving Françoise as both primary heir and BSF president. Her father André Bettencourt, a former French politician, died in 2007. Her grandfather Eugène Schueller founded L'Oréal in 1909.
Evidence
1987-01-01 - 😇 - Bettencourt Schueller Foundation co-founded by Francoise and parents; she became president in 2017
2007-07-06 - 😈 - French appeals court convicts L'Oreal's Garnier unit and Adecco of racist recruitment (whites-only BBR campaign); upheld by Cour de cassation 2009
2014-12-18 - 😈 - French Competition Authority fines L'Oreal EUR 189.5M for personal-care price-fixing cartel; fine upheld by Cour de cassation 2023
2019-04-18 - 😇 - Francoise Bettencourt Meyers pledges EUR 100M personally for Notre-Dame restoration
2020-02-17 - 😇 - Bettencourt Schueller Foundation sponsors Paris Opera Academy artisan training residencies
2020-02-25 - 😇 - L'Oreal named one of Ethisphere's 2020 World's Most Ethical Companies, its 10th such recognition
2022-01-01 - 😇 - Impulscience program awards EUR 2.3M each to 7 mid-career life sciences researchers annually
2022-10-01 - 😈 - L'Oreal hair relaxer cancer MDL: thousands of lawsuits alleging uterine and ovarian cancer from PFAS / EDC chemicals
2023-01-05 - 😇 - L'Oreal unveils HAPTA, a motion-stabilizing makeup applicator for people with limited hand and arm mobility, at CES 2023
2023-11-13 - 😇 - L'Oreal For Women in Science 2023: USD 60K to each of five women researchers, USD 5M+ total since 2003
2023-11-16 - 😇 - L'Oreal Share and Care: cancer support, domestic violence aid, and living wage for employees globally
2024-01-01 - 😈 - L'Oreal continues funding Chinese government animal testing despite 2023 opt-out option becoming available
2024-01-01 - 😇 - Bettencourt Schueller Foundation Solidarity: 48 projects, EUR 11.9M, benefiting 65,000 people in 2024
2025-01-01 - 😇 - Bettencourt Schueller Foundation allocates EUR 54.7M in annual grants including EUR 16.5M for life sciences
2025-03-10 - 😈 - L'Oreal recalls all lots of Effaclar Duo acne treatment in the US over benzene (carcinogen) contamination
2025-04-17 - 😈 - L'Oreal misses 2025 sustainability packaging targets: only 49% recyclable vs 100% goal
2025-11-12 - 😇 - L'Oreal USA 2025 For Women in Science: five postdoctoral scientists awarded research grants
2026-01-15 - 😇 - L'Oreal awarded EcoVadis Platinum Medal for fourth consecutive year, score 89 / 100, top 1% of 150,000 companies assessed
2026-03-05 - 😇 - L'Oreal commits additional EUR 50M to L'Oreal Fund for Women, renewed 2026-2030, targeting 5M women helped by 2030
2026-03-30 - 😈 - France 2 Cash Investigation finds allergenic PPD chemical in 51-96% of tested L'Oreal-group hair colorations, legal but flagged since 2013 EU rule
Analysis
Françoise Bettencourt Meyers is a notable example of wealth concentrated in inherited cosmetics holdings directed substantially toward philanthropy. The Bettencourt Schueller Foundation is one of France's largest private foundations, and her EUR 100M personal pledge for Notre-Dame restoration was among the single largest individual philanthropic commitments in French history.
She also brought the December 2007 criminal complaint that exposed the exploitation of her ailing mother: photographer François-Marie Banier was convicted in 2015 of abusing Liliane Bettencourt's weakness and ordered to repay EUR 158M. L'Oréal was also awarded EcoVadis's Platinum medal for a fourth consecutive year in January 2026, ranking it in the top 1% of over 150,000 companies assessed for environmental and social performance.
The primary concerns with her record involve L'Oréal's corporate practices during her 28 years as a board member. Its Garnier unit and the staffing agency Adecco were convicted of running a whites-only recruitment campaign for sales staff, the first racial-discrimination conviction of blue-chip companies in France. The French Competition Authority fined L'Oréal EUR 189.5M in 2014 for a personal-care price-fixing cartel that kept consumer prices artificially high, a fine upheld on final appeal in 2023.
The hair relaxer mass-tort litigation names L'Oréal products, marketed primarily to Black women, in thousands of lawsuits alleging endocrine-disrupting chemicals caused uterine and ovarian cancer. In March 2025, L'Oréal recalled all US lots of its Effaclar Duo acne treatment after testing found the carcinogen benzene, and its ongoing China-market animal testing remains a documented harm even after regulatory opt-out pathways emerged in 2023. In March 2026, the French investigative program Cash Investigation found the allergen PPD in the large majority of tested L'Oréal-group hair colorations, a legal but EU-flagged practice in a product line generating EUR 3.5B in annual sales.
These are serious company-level harms that Françoise, as vice chair and roughly a third family shareholder, materially benefited from; her sons now hold the same board seats and the family's ownership stake is unchanged since her 2025 retirement. They weigh against a philanthropy record that is nonetheless genuine, large in scale, and spans science, arts, and social inclusion, including a renewed EUR 50M commitment to the L'Oréal Fund for Women through 2030 announced in March 2026.
Questions
Does serving as a non-executive board member and inheritor, rather than as a founder or operational CEO, reduce Françoise's personal moral responsibility for L'Oréal's product safety failures, discrimination findings, cartel conduct, and animal testing practices?
How should the hair relaxer litigation be weighed? The products were marketed specifically to Black women with documented cancer risk, raising questions about both consumer harm and racial health equity. Does the scope of this harm counterbalance a philanthropy record of similar scale?
Is the Bettencourt Schueller Foundation's focus on French cultural prestige and elite scientific research meaningfully redistributive, or does it primarily benefit already-privileged institutions and researchers?
Françoise retired from the L'Oréal board in April 2025, and her sons now hold the same governance seats while the family's ownership stake is unchanged. How much personal weight should attach to company practices, like the PPD hair-dye findings, first documented after her own board departure but continuous with product lines and family control that predate it?
Redemption Arc
Françoise stepped back from the L'Oréal board in 2025, transferring governance responsibilities to her sons while the BSF continues to expand its funding, including the March 2026 renewal of the L'Oréal Fund for Women through 2030. L'Oréal's EcoVadis rating shows continued strength on independently assessed sustainability metrics. At the same time, new company-level product-safety findings, including the March 2026 hair-dye allergen report, continue to surface alongside the unresolved benzene recall, hair relaxer MDL, and animal testing concerns, all still open at the company level beyond her direct board tenure.